Cellular and molecular pharmacological studies on disturbance of CaィイD12+ィエD1 regulatory mechanisms in cardiomyocytes in diabetes
糖尿病心肌细胞CaD12+D1调节机制紊乱的细胞和分子药理学研究
基本信息
- 批准号:10670077
- 负责人:
- 金额:$ 0.32万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The present work was carried out in order to determine whether a decrease in cardiac NaィイD2+ィエD2-CaィイD22+ィエD2 exchanger (NCX) activity observed in diabetes is caused by a reduction in NCX protein and mRNA levels and to elucidate the significance of this decrease in alterations in [CaィイD12+ィエD1]ィイD2iィエD2 homeostasis in diabetic cardiomyocytes. The NCX current was significantly reduced in ventricular myocytes freshly isolated from streptozotocin-induced diabetic rat hearts, and its current density was about 55% of age-matched controls. Diabetes resulted in a 〜30% decrease in cardiac protein and mRNA levels of NCX1, a NCX isoform which is expressed at high levels in the heart. The reduced NCX current and the decreased protein and mRNA levels of NCX 1 in diabetes were prevented by insulin therapy. Although both diastolic and peak systolic [CaィイD22+ィエD2]ィイD2iィエD2 were not different between the two groups of myocytes, increasing external CaィイD12+ィエD1 concentration to high levels greatly elev … More ated diastolic [CaィイD12+ィエD1]ィイD2iィエD2 in diabetic myocytes. Inhibition of NCX by reduction in extracellular NaィイD1+ィエD1 by 50% could produce a marked rise in diastolic [CaィイD12+ィエD1]ィイD2iィエD2 in control myocytes in response to high CaィイD12+ィエD1, as seen in diabetic myocytes. However, cyclopiazonic acid, an inhibitor of sarcoplasmic reticulum CaィイD12+ィエD1 pump ATPase, did not modify the high CaィイD12+ィエD1-induced changes in diastolic [CaィイD12+ィエD1]I in either control and diabetic myocytes. Only in papillary muscles from diabetic rats, the addition of high CaィイD12+ィエD1 caused a marked rise in resting tension signifying a partial contracture that is possibly due to an increase in diastolic [CaィイD12+ィエD1]ィイD2iィエD2.In conclusion, a diminished NCX function in diabetic myocyes shown in this study results in part from the decreased levels of cardiac NCX protein and mRNA. We suggest that this impaired NCX function may play an important role in alterations in CaィイD12+ィエD1 handling when [CaィイD12+ィエD1]ィイD2iィエD2 rises to pathological levels. Less
The present work was carried out in order to determine whether a decrease in cardiac Naii D2+Ie D2-Caii D22+Ie D2 exchanger (NCX) activity observed in diabetes is caused by a reduction in NCX protein and mRNA levels and to elucidate the significance of this decrease in alterations in [Caii D12+Ie D1]Ie D2ii D2 homeostasis in diabetic心肌细胞。从链蛋白酶诱导的糖尿病大鼠心脏分离的心室肌细胞中,NCX电流显着降低,其电流密度约为年龄匹配的对照组的55%。糖尿病导致心脏蛋白和mRNA水平NCX1(一种NCX同工型)降低约30%,在心脏中高水平表达。通过胰岛素治疗预防NCX电流降低的NCX电流以及糖尿病中NCX 1的蛋白质和mRNA水平的降低。尽管两组肌细胞之间的糖尿病患者和峰值收缩期[CAI D22+E D2] II D2I D2并没有差异,在糖尿病性肌细胞中,将外部CAI D12+E D1浓度增加到高水平的高水平……更高的舒张压[CAI D12+E D1] II D2I D2。通过抑制糖尿病高的高CAI D12+IE D1,通过将细胞外NAI D1+E D1降低50%通过将NAI D1+E D1降低50%的抑制作用可能会产生明显的舒张压[CAI D12+E D1] II D2I D2。然而,环磷酸是肌浆网的抑制剂CAI D12+IE D1泵ATPase,在对照和糖尿病性肌动物中都没有修改高CAI D12+IE D1诱导的舒张期[CAI D12+IE D1] I的变化。 Only in papillary muscles from diabetic rats, the addition of high Cai D12+Ie D1 caused a marked rise in resting tension signing a partial contracture that is likely due to an increase in diastolic [Cai D12+Ie D1] Ii D2i D2.In conclusion, a diminished NCX function in diabetic myocyes shown in this study results in part from the decreased levels of cardiac NCX protein and mRNA。我们建议,当[CAI D12+IE D1] II D2I D2上升到病理水平时,这种受损的NCX功能可能在CAI D12+IE D1处理的改变中起重要作用。较少的
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
服部 裕一ほか: "細胞内Ca^<2+>調節機構および情報伝達系からみた糖尿病心の異常"Therapeutic Research. 21(3)(印刷中). (2000)
Yuichi Hattori 等:“从细胞内Ca^2+调节机制和信息转导系统的角度观察糖尿病心脏的异常”治疗研究21(3)(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hattori Y, Matsuda M, Gando S: "Abnormalities of intracellular CaィイD12+ィエD1 regulatory mechanisms and beta-adrenoceptor signaling pathways in diabetic hearts"Therapeutic Research. 21(3) (in press). (2000)
Hattori Y、Matsuda M、Gando S:“糖尿病心脏中细胞内 CaD12+D1 调节机制和 β-肾上腺素受体信号通路的异常”治疗研究 21(3)(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HATTORI Yuichi其他文献
HATTORI Yuichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HATTORI Yuichi', 18)}}的其他基金
Prophylactic and therapeutic strategy based on the molecular pathology of septic disseminated intravascular coagulation (DIC)
基于脓毒症播散性血管内凝血(DIC)分子病理学的预防和治疗策略
- 批准号:
17K08586 - 财政年份:2017
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Potential therapeutic application of epigenetic mechanisms involved in the septic pathology
脓毒症病理学表观遗传机制的潜在治疗应用
- 批准号:
23590298 - 财政年份:2011
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The transcription factor AP-1 as a molecular target in sepsis therapy
转录因子 AP-1 作为脓毒症治疗的分子靶点
- 批准号:
20590250 - 财政年份:2008
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of e-Learning contents for clinical medicine analyses supporter
为临床医学分析支持者开发电子学习内容
- 批准号:
19500834 - 财政年份:2007
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Potential usefulness of siRNAs for gene therapy ofsepsis-induced multiple organ failure
siRNA 在脓毒症引起的多器官衰竭基因治疗中的潜在用途
- 批准号:
18590233 - 财政年份:2006
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of irradiation-induced impairment eNOS expression
辐射诱导 eNOS 表达损伤的分子机制
- 批准号:
12670077 - 财政年份:2000
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cellular and molecular pharmacological studies on a role of tyrosine kinase in the signal transduction system in cardiac cells.
酪氨酸激酶在心肌细胞信号转导系统中作用的细胞和分子药理学研究。
- 批准号:
07670098 - 财政年份:1995
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on the role of protein kinase C in cardiac contractility
蛋白激酶C在心肌收缩力中作用的研究
- 批准号:
03670087 - 财政年份:1991
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
15-脂氧合酶及其代谢产物15-HpETE在缺血再灌注损伤诱发心肌细胞铁死亡过程中的调控作用和机制研究
- 批准号:82370295
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
E3泛素连接酶Fbxo7通过调节心肌细胞线粒体-内质网稳态减轻急性心肌缺血损伤及其机制研究
- 批准号:82370334
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PIEZO1点突变诱导心肌细胞铁死亡在心力衰竭中的作用及机制研究
- 批准号:82302463
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
心肌细胞自分泌肽PDRPS7通过调控JAB1功能抑制心肌缺血再灌注损伤的实验研究
- 批准号:82370341
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
内皮祖细胞源微粒通过SIRT1调控GM130/PGC-1α抑制缺血再灌注心肌细胞焦亡的分子机制
- 批准号:82360068
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Smart drug evaluation system for matured engineered cardiomyocyte tissue
成熟工程化心肌细胞组织智能药物评价系统
- 批准号:
23H01382 - 财政年份:2023
- 资助金额:
$ 0.32万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
虚拟药物筛选揭示了心肌细胞肥大的情境依赖性抑制
- 批准号:
10678351 - 财政年份:2023
- 资助金额:
$ 0.32万 - 项目类别:
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 0.32万 - 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
- 批准号:
10751640 - 财政年份:2023
- 资助金额:
$ 0.32万 - 项目类别:
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
免疫反应介导的心肌细胞生长和更新调节
- 批准号:
10625948 - 财政年份:2023
- 资助金额:
$ 0.32万 - 项目类别: